Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Open Label, Multicenter, Efficacy and Safety Study of Several Infusions of HepaStem in Urea Cycle Disorders Paediatric Patients

NCT02489292 is registered in ClinicalTrials.gov with Cellaion SA as lead sponsor.

NCT NCT02489292
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02489292 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Open Label, Multicenter, Efficacy and Safety Study of Several Infusions of HepaStem in Urea Cycle Disorders Paediatric Patients
Lead sponsor
Cellaion SA
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2014
Completion date
March 31, 2017
Enrollment
5 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

urea cycle disorders